Searched over 200M research papers
10 papers analyzed
These studies suggest that diabetes mellitus medications include pharmacological approaches like insulin and metformin, multi-target drugs, gene therapy, drug delivery systems, nanotechnology-based approaches, natural therapeutic products, and hydroxychloroquine, all aimed at improving blood glucose levels and managing diabetes comorbidities.
20 papers analyzed
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia, affecting millions globally. The management of diabetes, particularly Type 2 diabetes mellitus (T2DM), involves a variety of pharmacological and non-pharmacological approaches aimed at controlling blood glucose levels and mitigating complications .
Insulin therapy is essential for Type 1 diabetes mellitus (T1DM) and often used in advanced T2DM. Insulin analogs, designed to mimic natural insulin, help in maintaining glucose homeostasis . However, long-term insulin therapy can lead to adverse effects such as hypoglycemia and weight gain.
Drugs like sulfonylureas and meglitinides stimulate insulin secretion from pancreatic beta cells. These are commonly used in T2DM but can cause hypoglycemia and weight gain .
Biguanides (e.g., metformin) and thiazolidinediones improve insulin sensitivity. Metformin is often the first-line treatment for T2DM due to its efficacy and safety profile, though it can cause gastrointestinal issues .
These drugs, including acarbose and miglitol, slow carbohydrate absorption in the intestines, helping to control postprandial blood glucose levels .
These drugs enhance insulin secretion in response to meals and have additional benefits like weight loss. They are generally safe but can cause gastrointestinal side effects .
Dipeptidyl peptidase-4 inhibitors prolong the action of incretin hormones, aiding in glucose regulation. They are well-tolerated but may cause nasopharyngitis and headaches .
Sodium-glucose co-transporter 2 inhibitors reduce blood glucose by increasing urinary glucose excretion. They also offer cardiovascular benefits but can lead to urinary tract infections and euglycemic diabetic ketoacidosis .
Gene therapy and induced beta-cell regeneration are promising but not yet widely adopted. These approaches aim to restore normal insulin production and function.
Nanotechnology offers site-specific drug delivery, improving bioavailability and reducing dosage frequency. This approach is particularly beneficial for drugs with poor gastrointestinal absorption.
Originally used for malaria and autoimmune diseases, hydroxychloroquine has shown potential in improving insulin sensitivity and reducing blood glucose levels in diabetes patients.
Dietary changes and increased physical activity are fundamental in managing diabetes. These interventions can significantly improve glucose control and reduce the need for medication.
Natural products like resveratrol, curcumin, and various plant extracts have shown antidiabetic properties. They can be used as supplements to enhance the efficacy of conventional therapies and reduce side effects .
The management of diabetes mellitus involves a multifaceted approach, combining pharmacological treatments with lifestyle modifications. While conventional medications like insulin and oral hypoglycemics remain the cornerstone of diabetes management, emerging therapies and natural products offer promising alternatives. Continuous research and innovation are essential to develop more effective and safer treatments for diabetes mellitus.
Most relevant research papers on this topic